Biomarker Documentation in the Community Setting: Improving Clinical Decision Support With Daniel Rubin, PharmD
Expert Perspectives · Keira Smith · 2024-07-19
At this year’s American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Daniel Rubin, PharmD, Senior Manager of Clinical Content at McKesson Specialty Health and the US Oncology Network, presented an abstract entitled, “Impact on biomarker documentation in community oncology by optimizing clinical decision support.” Following this, he sat down with Oncology Data Advisor to further discuss biomarker documentation in the community setting, including:
- How biomarker testing is used to inform treatment decisions in oncology
- The challenges surrounding biomarker documentation and unknown results
- The clinical decision support (CDS) tool that he and his team developed, what it involves, and what it aims to provide
- How the CDS tool performed in documenting biomarker results for non–small cell lung cancer and castration-resistant prostate cancer and the significance of these results for informing treatment decisions
- And more!
About Dr. Rubin
Daniel Rubin, PharmD, is the Senior Manager of Clinical Content at McKesson Specialty Health and the US Oncology Network. His work and research focus on the intersection of oncology, treatment guidelines, and clinical decision support.